Uric acid and cardiovascular events: A Mendelian randomization study

Journal of the American Society of Nephrology

Volumn 26, Issue 11, 2015, Pages 2831-2838

  Kleber, Marcus E ^a   Delgado, Graciela ^a   Grammer, Tanja B ^a   Silbernagel, Günther ^b   Huang, Jie ^c   Krämer, Bernhard K ^a   Ritz, Eberhard ^d   März, Winfried ^a,e,f  

^a MEDICAL FACULTY MANNHEIM HEIDELBERG UNIVERSITY   (Germany)

^b BERN UNIVERSITY HOSPITAL   (Switzerland)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^d UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^e MEDICAL UNIVERSITY OF GRAZ   (Austria)

^f SYNLAB ACADEMY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; GAMMA GLUTAMYLTRANSFERASE; GCKR PROTEIN; GLUCOSE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTEIN; SLC2A9 PROTEIN; TMEM171 PROTEIN; UNCLASSIFIED DRUG; URIC ACID; BIOLOGICAL MARKER;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CORONARY ARTERY DISEASE; DIASTOLIC BLOOD PRESSURE; FEMALE; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MALE; MENDELIAN RANDOMIZATION ANALYSIS; PLEIOTROPY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SUDDEN CARDIAC DEATH; SYSTOLIC BLOOD PRESSURE; URIC ACID BLOOD LEVEL; AGED; BIOLOGICAL MODEL; BLOOD; CHEMISTRY; CROSS-SECTIONAL STUDY; DNA MICROARRAY; FOLLOW UP; GENETICS; GENOTYPE; HYPERTENSION; HYPERURICEMIA; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PHENOTYPE; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; REGRESSION ANALYSIS; RISK FACTOR;

AGED; BIOMARKERS; CARDIOVASCULAR DISEASES; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; HYPERTENSION; HYPERURICEMIA; MALE; MENDELIAN RANDOMIZATION ANALYSIS; MIDDLE AGED; MODELS, GENETIC; MULTIVARIATE ANALYSIS; ODDS RATIO; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS; URIC ACID;

EID: 84941971658     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2014070660     Document Type: Article

References (55)

1. Wu XW, Muzny DM, Lee CC, Caskey CT: Two independent mutational events in the loss of urate oxidase during hominoid evolution. J Mol Evol 34: 78-84, 1992
2. Ames BN, Cathcart R, Schwiers E, Hochstein P: Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: A hypothesis. Proc Natl Acad Sci U S A 78: 6858 6862, 1981
3. Fabbrini E, Serafini M, Colic Baric I, Hazen SL, Klein S: Effect of plasma uric acid on antioxidant capacity, oxidative stress, and insulin sensitivity in obese subjects. Diabetes 63: 976-981, 2014
4. Watanabe S, Kang DH, Feng L, Nakagawa T, Kanellis J, Lan H, Mazzali M, Johnson RJ: Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity. Hypertension 40: 355-360, 2002
5. Weaver AL: Epidemiology of gout. Cleve Clin J Med 75[Suppl 5]: S9 S12, 2008
6. Rho YH, Zhu Y, Choi HK: The epidemiology of uric acid and fructose. Semin Nephrol 31: 410-419, 2011
7. Choi JW, Ford ES, Gao X, Choi HK: Sugar-sweetened soft drinks, diet soft drinks, and serum uric acid level: The Third National Health and Nutrition Examination Survey. Arthritis Rheum 59: 109-116, 2008
8. Lennane GA, Rose BS, Isdale IC: Gout in the Maori. Ann Rheum Dis 19: 120-125, 1960
9. Kagan A, Harris BR, Winkelstein W Jr, Johnson KG, Kato H, Syme SL, Rhoads GG, Gay ML, Nichaman MZ, Hamilton HB, Tillotson J: Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: Demographic, physical, dietary and biochemical characteristics. J Chronic Dis 27: 345-364, 1974
10. Johnson RJ, Titte S, Cade JR, Rideout BA, Oliver WJ: Uric acid, evolution and primitive cultures. Semin Nephrol 25: 3-8, 2005
11. Johnson RJ, SegalMS, Sautin Y, Nakagawa T, Feig DI, KangDH, Gersch MS, Benner S, Sánchez-Lozada LG: Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Am J Clin Nutr 86: 899-906, 2007
12. Smith GD, Ebrahim S: 'Mendelian randomization': Can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 32: 1-22, 2003
13. Rice T, Vogler GP, Perry TS, Laskarzewski PM, Province MA, Rao DC: Heterogeneity in the familial aggregation of fasting serum uric acid level in five North American populations: The Lipid Research Clinics Family Study. Am J Med Genet 36: 219-225, 1990
14. Kalousdian S, Fabsitz R, Havlik R, Christian J, Rosenman R: Heritability of clinical chemistries in an older twin cohort: The NHLBI Twin Study. Genet Epidemiol 4: 1-11, 1987
15. Nath SD, Voruganti VS, Arar NH, Thameem F, Lopez-Alvarenga JC, Bauer R, Blangero J, MacCluer JW, Comuzzie AG, Abboud HE: Genome scan for determinants of serum uric acid variability. J Am Soc Nephrol 18: 3156-3163, 2007
16. Köttgen A, Albrecht E, Teumer A, Vitart V, Krumsiek J, Hundertmark C, Pistis G, Ruggiero D, O'Seaghdha CM, Haller T, Yang Q, Tanaka T, Johnson AD, Kutalik Z, Smith AV, Shi J, Struchalin M, Middelberg RP, BrownMJ, Gaffo AL, PirastuN, LiG, Hayward C, Zemunik T, Huffman J, Yengo L, Zhao JH, Demirkan A, Feitosa MF, Liu X, Malerba G, Lopez LM, van der Harst P, Li X, Kleber ME, Hicks AA, Nolte IM, Johansson A, Murgia F, Wild SH, Bakker SJ, Peden JF, Dehghan A, Steri M, Tenesa A, Lagou V, Salo P, Mangino M, Rose LM, Lehtimäki T, Woodward OM, Okada Y, Tin A, Müller C, Oldmeadow C, Putku M, Czamara D, Kraft P, Frogheri L, Thun GA, Grotevendt A, Gislason GK, Harris TB, Launer LJ, McArdle P, Shuldiner AR, Boerwinkle E, Coresh J, Schmidt H, Schallert M, Martin NG, Montgomery GW, Kubo M, Nakamura Y, Tanaka T, Munroe PB, Samani NJ, Jacobs DR Jr, Liu K, D'Adamo P, Ulivi S, Rotter JI, Psaty BM, Vollenweider P, Waeber G, Campbell S, Devuyst O, Navarro P, Kolcic I, Hastie N, Balkau B, Froguel P, Esko T, Salumets A, Khaw KT, LangenbergC,WarehamNJ, Isaacs A, Kraja A, ZhangQ,Wild PS, Scott RJ, Holliday EG, Org E, Viigimaa M, Bandinelli S, Metter JE, Lupo A, Trabetti E, Sorice R, Döring A, Lattka E, Strauch K, Theis F, Waldenberger M, Wichmann HE, Davies G, Gow AJ, Bruinenberg M, Stolk RP, Kooner JS, Zhang W, Winkelmann BR, Boehm BO, Lucae S, Penninx BW, Smit JH, Curhan G, Mudgal P, Plenge RM, Portas L, Persico I, Kirin M, Wilson JF, Mateo Leach I, van Gilst WH, Goel A, Ongen H, Hofman A, Rivadeneira F, Uitterlinden AG, Imboden M, von Eckardstein A, Cucca F, Nagaraja R, Piras MG, Nauck M, Schurmann C, Budde K, Ernst F, Farrington SM, Theodoratou E, Prokopenko I, Stumvoll M, Jula A, Perola M, Salomaa V, Shin SY, Spector TD, Sala C, Ridker PM, KähönenM, Viikari J, Hengstenberg C, Nelson CP,Meschia JF, Nalls MA, Sharma P, Singleton AB, Kamatani N, Zeller T, Burnier M, Attia J, LaanM, Klopp N, Hillege HL, Kloiber S, Choi H, Pirastu M, Tore S, Probst-Hensch NM, Völzke H, Gudnason V, Parsa A, Schmidt R, Whitfield JB, Fornage M, Gasparini P, Siscovick DS, Pola?ek O, Campbell H, Rudan I, Bouatia-Naji N, Metspalu A, Loos RJ, van Duijn CM, Borecki IB, Ferrucci L, Gambaro G, Deary IJ, Wolffenbuttel BH, Chambers JC,MärzW, Pramstaller PP, Snieder H, Gyllensten U,Wright AF, Navis G, Watkins H, Witteman JC, Sanna S, Schipf S, Dunlop MG, Tönjes A, Ripatti S, Soranzo N, Toniolo D, Chasman DI, RaitakariO, Kao WH, Ciullo M, Fox CS, Caulfield M, Bochud M, Gieger C; LifeLines Cohort StudyCARDIoGRAM ConsortiumDIAGRAM ConsortiumICBP ConsortiumMAGIC Consortium: Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet 45: 145-154, 2013
17. Silbernagel G, Hoffmann MM, Grammer TB, Boehm BO, März W: Uric acid is predictive of cardiovascular mortality and sudden cardiac death in subjects referred for coronary angiography. Nutr Metab Cardiovasc Dis 23: 46-52, 2013
18. Tyler AL, Asselbergs FW, Williams SM, Moore JH: Shadows of complexity: What biological networks reveal about epistasis and pleiotropy. Bioessays 31: 220-227, 2009
19. Burgess S, Daniel RM, Butterworth AS, Thompson SG; EPIC-InterAct Consortium:NetworkMendelian randomization: Using genetic variants as instrumental variables to investigate mediation in causal pathways [published online ahead of print August 22, 2014]. Int J Epidemiol doi: 10.1093/ije/dyu176
20. Friesinger GC, Page EE, Ross RS: Prognostic significance of coronary arteriography. Trans Assoc Am Physicians 83: 78-92, 1970
21. Wang J, Qin T, Chen J, Li Y,Wang L, Huang H, Li J: Hyperuricemia and risk of incident hypertension: A systematic review and meta-analysis of observational studies. PLoS ONE 9: e114259, 2014
22. Mazzali M, Hughes J, Kim YG, Jefferson JA, Kang DH, Gordon KL, Lan HY, Kivlighn S, Johnson RJ: Elevated uric acid increases blood pressure in the rat by a novel crystal-independentmechanism. Hypertension 38: 1101-1106, 2001
23. Feig DI, Soletsky B, Johnson RJ: Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: A randomized trial. JAMA 300: 924-932, 2008
24. Palmer TM, Nordestgaard BG, Benn M, Tybj?rg-Hansen A, Davey Smith G, Lawlor DA, Timpson NJ: Association of plasma uric acid with ischaemic heart disease and blood pressure: Mendelian randomisation analysis of two large cohorts. BMJ 347: f4262, 2013
25. Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA: Hyperuricemia and risk of stroke: A systematic review and meta-analysis. Arthritis Rheum 61: 885-892, 2009
26. Ekundayo OJ, Dell'Italia LJ, Sanders PW, Arnett D, Aban I, Love TE, Filippatos G, Anker SD, Lloyd-Jones DM, Bakris G, Mujib M, Ahmed A: Associationbetween hyperuricemia and incident heart failureamong older adults: A propensity-matched study. Int J Cardiol 142: 279-287, 2010
27. Bos MJ, Koudstaal PJ, Hofman A,Witteman JC, Breteler MM: Uric acid is a risk factor for myocardial infarction and stroke: The Rotterdam study. Stroke 37: 1503-1507, 2006
28. Zhao G, Huang L, Song M, Song Y: Baseline serum uric acid level as a predictor of cardiovascular disease relatedmortality and all-cause mortality: A meta-analysis of prospective studies. Atherosclerosis 231: 61-68, 2013
29. Skak-Nielsen H, Torp-Pedersen C, Finer N, Caterson ID, Van Gaal L, James WP, Maggioni AP, Sharma AM, Coutinho W, Andersson C: Uric acid as a risk factor for cardiovascular disease and mortality in overweight/obese individuals. PLoS ONE 8: e59121, 2013
30. Thornley S, Marshall RJ, Jackson R, Gentles D, Dalbeth N, Crengle S, Kerr A, Wells S: Is serum urate causally associated with incident cardiovascular disease? Rheumatology (Oxford) 52: 135-142, 2013
31. Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA: Hyperuricemia and coronary heart disease: A systematic review and metaanalysis. Arthritis Care Res (Hoboken) 62: 170-180, 2010
32. Yang Q, Köttgen A, Dehghan A, Smith AV, Glazer NL, Chen MH, Chasman DI, Aspelund T, Eiriksdottir G, Harris TB, Launer L, Nalls M, Hernandez D, Arking DE, Boerwinkle E, GroveML, Li M, Linda KaoWH, ChoncholM,Haritunians T, Li G, Lumley T, Psaty BM, ShlipakM,Hwang SJ, Larson MG, O'Donnell CJ, Upadhyay A, van Duijn CM, Hofman A, Rivadeneira F, Stricker B, Uitterlinden AG, Paré G, Parker AN, Ridker PM, Siscovick DS, Gudnason V, Witteman JC, Fox CS, Coresh J: Multiple genetic loci influence serum urate levels and their relationshipwith gout and cardiovascular disease risk factors. Circ Cardiovasc Genet 3: 523-530, 2010
33. Meisinger C, Koenig W, Baumert J, Döring A: Uric acid levels are associated with all-cause and cardiovascular disease mortality independent of systemic inflammationinmenfromthegeneral population: TheMONICA/KORA cohort study. Arterioscler Thromb Vasc Biol 28: 1186-1192, 2008
34. Fang J, AldermanMH: Serumuric acid and cardiovascularmortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA 283: 2404-2410, 2000
35. Lin GM, Li YH, Zheng NC, Lai CP, Lin CL, Wang JH, Jaiteh LE, Han CL: Serum uric acid as an independent predictor of mortality in high-risk patients with obstructive coronary artery disease: A prospective observational cohort study from the ET-CHD registry, 1997-2003. J Cardiol 61: 122-127, 2013
36. Culleton BF, Larson MG, Kannel WB, Levy D: Serum uric acid and risk for cardiovascular disease and death: The Framingham Heart Study. Ann Intern Med 131: 7-13, 1999
37. Jee SH, Lee SY, Kim MT: Serum uric acid and risk of death from cancer, cardiovascular disease or all causes in men. Eur J Cardiovasc Prev Rehabil 11: 185-191, 2004
38. Kivity S, Kopel E, Maor E, Abu-Bachar F, Segev S, Sidi Y, Olchovsky D: Association of serum uric acid and cardiovascular disease in healthy adults. Am J Cardiol 111: 1146-1151, 2013
39. Chung W, Kim AJ, Ro H, Chang JH, Lee HH, Jung JY: Hyperuricemia is an independent risk factor for mortality only if chronic kidney disease is present. Am J Nephrol 37: 452-461, 2013
40. Johnson RJ, Rideout BA: Uric acid and diet-insights into the epidemic of cardiovascular disease. N Engl J Med 350: 1071-1073, 2004
41. Mitsuhashi H, Yatsuya H, Matsushita K, Zhang H, Otsuka R, Muramatsu T, Takefuji S, Hotta Y, Kondo T, Murohara T, Toyoshima H, Tamakoshi K: Uric acid and left ventricular hypertrophy in Japanese men. Circulation 73: 667-672, 2009
42. Fujita S, Okamoto Y, Shibata K, Morita H, Ito T, Sohmiya K, Hoshiga M, Ishizaka N: Serum uric acid is associated with left ventricular hypertrophy independent of serum parathyroid hormone in male cardiac patients. PLoS ONE 8: e82735, 2013
43. Yamada S, Suzuki H, Kamioka M, Kamiyama Y, Saitoh S, Takeishi Y: Uric acid increases the incidence of ventricular arrhythmia in patients with left ventricular hypertrophy. Fukushima J Med Sci 58: 101-106, 2012
44. Nyrnes A, Toft I, Njolstad I, Mathiesen EB, Wilsgaard T, Hansen JB, Løchen ML: Uric acid is associated with future atrial fibrillation: An 11 year follow-up of 6308 men and women-the Tromso Study. Europace 16: 320-326, 2014.
45. Chao TF, Liu CJ, Chen SJ, Wang KL, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Chen TJ, Tsao HM, Chen SA: Hyperuricemia and the risk of ischemic stroke in patients with atrial fibrillation-could it refine clinical risk stratification in AF? Int J Cardiol 170: 344-349, 2014
46. Rock KL, Kataoka H, Lai JJ: Uric acid as a danger signal in gout and its comorbidities. Nat Rev Rheumatol 9: 13-23, 2013
47. Mulay SR, Evan A, Anders HJ: Molecular mechanisms of crystal-related kidney inflammation and injury. Implications for cholesterol embolism, crystalline nephropathies and kidney stone disease. Nephrol Dial Transplant 29: 507-514, 2014
48. Duncan DJ, Yang Z, Hopkins PM, Steele DS, Harrison SM: TNF-alpha and IL-1beta increase Ca2+ leak from the sarcoplasmic reticulum and susceptibility to arrhythmia in rat ventricular myocytes. Cell Calcium47: 378-386, 2010
49. Park JH, Jin YM, Hwang S, Cho DH, Kang DH, Jo I: Uric acid attenuates nitric oxide production by decreasing the interaction between endothelial nitric oxide synthase and calmodulin in human umbilical vein endothelial cells: A mechanism for uric acid-induced cardiovascular disease development. Nitric Oxide 32: 36-42, 2013
50. Nyegaard M, Overgaard MT, Søndergaard MT, Vranas M, Behr ER, Hildebrandt LL, Lund J, Hedley PL, Camm AJ, Wettrell G, Fosdal I, Christiansen M, Børglum AD: Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death.AmJHumGenet 91: 703-712, 2012
51. Winkelmann BR, März W, Boehm BO, Zotz R, Hager J, Hellstern P, Senges J; LURIC Study Group (LUdwigshafen RIsk and Cardiovascular Health): Rationale and design of the LURIC study - A resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease. Pharmacogenomics 2[Suppl 1]: S1-S73, 2001
52. Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, Kusek JW, Manzi J, Van Lente F, Zhang YL, Coresh J, Levey AS; CKDEPI Investigators: Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 367: 20-29, 2012
53. Li Y, Willer CJ, Ding J, Scheet P, Abecasis GR: MaCH: Using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol 34: 816-834, 2010
54. Li Y, Willer C, Sanna S, Abecasis G: Genotype imputation. Annu Rev Genomics Hum Genet 10: 387-406, 2009
55. Palmer TM, Sterne JA, Harbord RM, Lawlor DA, Sheehan NA, Meng S, Granell R, Smith GD, Didelez V: Instrumental variable estimation of causal risk ratios and causal odds ratios in Mendelian randomization analyses. Am J Epidemiol 173: 1392-1403, 2011